Mfn2 modulates the UPR and mitochondrial function via repression of PERK
2014; Springer Nature; Volume: 33; Issue: 2 Linguagem: Inglês
10.1002/embj.201470050
ISSN1460-2075
AutoresJuan Pablo Muñoz, Saška Ivanova, Jana Sánchez, Paula Martínez-Cristóbal, Manuel Noguera, Ana Sancho, Angels Díaz‐Ramos, María Isabel Hernández‐Álvarez, David Sebastián, Caroline Mauvezin, Manuel Palacı́n, António Zorzano,
Tópico(s)ATP Synthase and ATPases Research
ResumoCorrigendum14 January 2014free access Mfn2 modulates the UPR and mitochondrial function via repression of PERK Juan Pablo Muñoz Juan Pablo Muñoz Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Saška Ivanova Saška Ivanova Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Jana Sánchez-Wandelmer Jana Sánchez-Wandelmer Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Paula Martínez-Cristóbal Paula Martínez-Cristóbal Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Eduard Noguera Eduard Noguera Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Ana Sancho Ana Sancho Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Angels Díaz-Ramos Angels Díaz-Ramos Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author María Isabel Hernández-Alvarez María Isabel Hernández-Alvarez Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author David Sebastián David Sebastián Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Caroline Mauvezin Caroline Mauvezin Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Manuel Palacín Manuel Palacín Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Antonio Zorzano Corresponding Author Antonio Zorzano Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Juan Pablo Muñoz Juan Pablo Muñoz Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Saška Ivanova Saška Ivanova Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Jana Sánchez-Wandelmer Jana Sánchez-Wandelmer Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Paula Martínez-Cristóbal Paula Martínez-Cristóbal Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Eduard Noguera Eduard Noguera Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Ana Sancho Ana Sancho Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Angels Díaz-Ramos Angels Díaz-Ramos Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author María Isabel Hernández-Alvarez María Isabel Hernández-Alvarez Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author David Sebastián David Sebastián Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Caroline Mauvezin Caroline Mauvezin Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Manuel Palacín Manuel Palacín Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Antonio Zorzano Corresponding Author Antonio Zorzano Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain Search for more papers by this author Author Information Juan Pablo Muñoz1,2,3, Saška Ivanova1,2,3, Jana Sánchez-Wandelmer1,2,3, Paula Martínez-Cristóbal1,2,3, Eduard Noguera1,2,3, Ana Sancho1,2,3, Angels Díaz-Ramos1,2,3, María Isabel Hernández-Alvarez1,2,3, David Sebastián1,2,3, Caroline Mauvezin1,2,3, Manuel Palacín1,2,3 and Antonio Zorzano 1,2,3 1Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain 2Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain 3CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain *Correspondence to: [email protected] The EMBO Journal (2014)33:171-171https://doi.org/10.1002/embj.201470050 This article corrects the following: Mfn2 modulates the UPR and mitochondrial function via repression of PERK06 August 2013 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Correction to: The EMBO Journal 32, 2348-2361 DOI 10.1038/emboj.2013.168 Since Advance Online Publication, an additional affiliation has been added for the author Manuel Palacín. The correct affiliations are shown above. The authors apologize for any inconvenience caused. Next ArticlePrevious Article Read MoreAbout the coverClose modalView large imageVolume 33,Issue 2,16 January 2014Cover: Fireworks? ‐ A grey crowned crane looking the other way, photographed by Carol Stocking and Vladimir Prassolov. Carol Stocking leads the Retroviral Pathogenesis Group at the Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany. Volume 33Issue 216 January 2014In this issue RelatedDetailsLoading ...
Referência(s)